Hyderabad-based drugmaker will license and supply 75 generic drugsthat address a $200m market to Pfizer
After trying it out for almost a year, the world's biggest drug-maker Pfizer Inc, has decided to turn copycat in right earnest. And the $50 billion giant will take the help of Hyderabad-based Aurobindo Pharma, an established copycat drug-maker, to make this happen.
The multinational will license 70 generic drugs and 12 sterile injectibles, including penicillins and cephalosporins, which according to industry watchers are valued at over $200 million in sales, from Aurobindo for marketing in the US, and Europe.
That is good news for Aurobindo but may not leave much for Pfizer to smile about, say analysts.
After trying it out for almost a year, the world's biggest drug-maker Pfizer Inc, has decided to turn copycat in right earnest. And the $50 billion giant will take the help of Hyderabad-based Aurobindo Pharma, an established copycat drug-maker, to make this happen. The multinational will license 70 generic drugs and 12 sterile injectibles, including penicillins and cephalosporins, which according to industry watchers are valued at over $200 million in sales, from Aurobindo for marketing in the US, and Europe. That is good news for Aurobindo but may not leave much for Pfizer to smile about, say analysts.
TV Today network, the promoter of Aaj Tak news channel, informed on Tuesday that it would buyback 10 per cent equity from public at Rs 115.
The offer price of Rs 115 is at a premium of 102 per cent to the company's yesterday's closing price Rs 56.95 on the NSE.
The company proposes to buy back a maximum of 47.79 lakh equity shares and a minimum of 2 lakh equity shares from existing shareholders at Rs 115 per share for an aggregate amount of about Rs 29.30 crore.
The buy back would commence on March 16 and would close on July 30, 2009.
Siemens VAI Metals Technologies, one of the world's leading engineering and plant-building companies for the iron and steel industry, has won an order worth euro 200 million from public sector Steel Authority of India Limited (SAIL).
The order is for public sector steel major SAIL's upcoming new steel mill, which will be built at the company's Bhilai unit.
For the latest awarded contract, Siemens VAI will engineer and supply three LD converters with a tapping weight of 180 tons.
The Tulsi Tanti-controlled wind turbine maker Suzlon Energy and China based Inner Mongolia North Longyuan Wind Power Corporation have formed a joint venture on Tuesday. The JV aims to supply wind turbines of 100 megawatt for a World Bank funded project in China. The company recently bagged order for 80 turbines from Inner Mongolia North Longyuan Wind Power Corporation.
The JV, signed by Chinese Subsidiary of Suzlon Energy, Suzlon Energy Tianjin, would ensure delivery of 80 units of Suzlon's 1.25 megawatt turbines in two lots in the financial years 2010 and 2011.
IT giant HCL Technologies has managed to bag an order worth Rs 393 crore from National Insurance Company (NIC) to provide information technology related services and operation management modules, necessary to equip NIC with cutting edge technology.
The company, for the project worth Rs 393-crore, is entitled to provide IT services and modernization of business process for a period of seven years to NIC.